133 related articles for article (PubMed ID: 27733072)
1. Not just leukemia: CMV may protect against lymphoma recurrence after allogeneic transplant.
Peled JU; Jenq RR
Leuk Lymphoma; 2017 Apr; 58(4):759-761. PubMed ID: 27733072
[No Abstract] [Full Text] [Related]
2. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
3. Impact of cytomegalovirus replication and cytomegalovirus serostatus on the outcome of patients with B cell lymphoma after allogeneic stem cell transplantation.
Mariotti J; Maura F; Spina F; Roncari L; Dodero A; Farina L; Montefusco V; Carniti C; Sarina B; Patriarca F; Rambaldi A; Onida F; Olivieri A; Zallio F; Corradini P
Biol Blood Marrow Transplant; 2014 Jun; 20(6):885-90. PubMed ID: 24583412
[TBL] [Abstract][Full Text] [Related]
4. Effect of Cytomegalovirus Reactivation on Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Leukemia.
Inagaki J; Noguchi M; Kurauchi K; Tanioka S; Fukano R; Okamura J
Biol Blood Marrow Transplant; 2016 Feb; 22(2):300-306. PubMed ID: 26371373
[TBL] [Abstract][Full Text] [Related]
5. The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation.
Webb BJ; Harrington R; Schwartz J; Kammerer J; Spalding J; Lee E; Dodds B; Kaufusi S; Goodman BE; Firth SD; Martin G; Sorensen J; Hoda D
Transpl Infect Dis; 2018 Oct; 20(5):e12961. PubMed ID: 29975816
[TBL] [Abstract][Full Text] [Related]
6. Distinct clinical features of infectious complications in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis in the Nagasaki transplant group.
Itonaga H; Taguchi J; Fukushima T; Tsushima H; Sato S; Ando K; Sawayama Y; Matsuo E; Yamasaki R; Onimaru Y; Imanishi D; Imaizumi Y; Yoshida S; Hata T; Moriuchi Y; Honda S; Miyazaki Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):607-15. PubMed ID: 23333533
[TBL] [Abstract][Full Text] [Related]
7. Impact of cytomegalovirus reactivation on relapse and survival in patients with acute leukemia who received allogeneic hematopoietic stem cell transplantation in first remission.
Yoon JH; Lee S; Kim HJ; Jeon YW; Lee SE; Cho BS; Lee DG; Eom KS; Kim YJ; Min CK; Cho SG; Min WS; Lee JW
Oncotarget; 2016 Mar; 7(13):17230-41. PubMed ID: 26883100
[TBL] [Abstract][Full Text] [Related]
8. [Cytomegalovirus infection after haploidentical stem cell transplantation may reduce relapse risk in leukemia].
Lin X; Ou Y; Long H; Huang Y; Song C; Lu Z; Guo K; Wu B; Xu J
Zhonghua Nei Ke Za Zhi; 2016 Feb; 55(2):107-10. PubMed ID: 26875578
[TBL] [Abstract][Full Text] [Related]
9. [Cytomegalovirus specific cytotoxic T lymphocytes for treatment of refractory cytomegalovirus infection in patients following allogeneic hematopoietic stem cell transplantation].
Xu Z; Huang X; Sun Y; Wang F; Yan C; Zhang X; Han W; Chen Y; Wang J; Chen H; Wang Y; Zhang Y; Liu K; Xu L
Zhonghua Nei Ke Za Zhi; 2015 Feb; 54(2):101-5. PubMed ID: 25907838
[TBL] [Abstract][Full Text] [Related]
10. Clinical Usefulness of Monitoring Cytomegalovirus-Specific Immunity by Quantiferon-CMV in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Lee SM; Kim YJ; Yoo KH; Sung KW; Koo HH; Kang ES
Ann Lab Med; 2017 May; 37(3):277-281. PubMed ID: 28224776
[TBL] [Abstract][Full Text] [Related]
11. The immune reconstitution after an allogeneic stem cell transplant correlates with the risk of graft-versus-host disease and cytomegalovirus infection.
Torelli GF; Lucarelli B; Iori AP; De Propris MS; Capobianchi A; Barberi W; Valle V; Iannella E; Natalino F; Mercanti C; Perrone S; Gentile G; Guarini A; Foà R
Leuk Res; 2011 Aug; 35(8):1124-6. PubMed ID: 21459444
[TBL] [Abstract][Full Text] [Related]
12. The significance of cytomegalovirus viremia at day 100 or more following allogeneic hematopoietic stem cell transplantation.
Rowe J; Grim SA; Peace D; Lai C; Sweiss K; Layden JE; Clark NM
Clin Transplant; 2013; 27(4):510-6. PubMed ID: 23621704
[TBL] [Abstract][Full Text] [Related]
13. [Prevention or treatment CMV infections after allogeneic hematopoietic stem cell transplant by cytomegalovirus specific T cells].
Jia JS; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2013 Mar; 34(3):269-72. PubMed ID: 23683433
[No Abstract] [Full Text] [Related]
14. Assessment of a cytomegalovirus serology dual-testing strategy in hematopoietic stem cell transplant recipients.
Perry DA; Hakki M
Transpl Infect Dis; 2016 Oct; 18(5):809-814. PubMed ID: 27502917
[TBL] [Abstract][Full Text] [Related]
15. The clinical impact of cytomegalovirus infection following allogeneic hematopoietic cell transplantation: Why the quest for meaningful prophylaxis still matters.
Chan ST; Logan AC
Blood Rev; 2017 May; 31(3):173-183. PubMed ID: 28173959
[TBL] [Abstract][Full Text] [Related]
16. Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation.
Borchers S; Luther S; Lips U; Hahn N; Kontsendorn J; Stadler M; Buchholz S; Diedrich H; Eder M; Koehl U; Ganser A; Mischak-Weissinger E
Transpl Infect Dis; 2011 Jun; 13(3):222-36. PubMed ID: 21585633
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Murex CMV DNA Hybrid Capture assay (version 2.0) for early diagnosis of cytomegalovirus infection in recipients of an allogeneic stem cell transplant.
Hebart H; Wuchter P; Loeffler J; Gscheidle B; Hamprecht K; Sinzger C; Jahn G; Dietz K; Kanz L; Einsele H
Bone Marrow Transplant; 2001 Jul; 28(2):213-8. PubMed ID: 11509941
[TBL] [Abstract][Full Text] [Related]
18. The role of cytomegalovirus serostatus on outcome of hematopoietic stem cell transplantation.
Ljungman P
Curr Opin Hematol; 2014 Nov; 21(6):466-9. PubMed ID: 25159712
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus DNAemia detected with real-time polymerase chain reaction in hematopoietic stem cell transplant patients.
Sahin DG; Gunduz E; Kasifoglu N; Akay OM; Us T; Gulbas Z
Adv Ther; 2013 Aug; 30(8):784-91. PubMed ID: 23959787
[TBL] [Abstract][Full Text] [Related]
20. Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure.
Nakamura R; Battiwalla M; Solomon S; Follmann D; Chakrabarti S; Cortez K; Hensel N; Childs R; Barrett AJ
Biol Blood Marrow Transplant; 2004 Jan; 10(1):49-57. PubMed ID: 14752779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
